Trial Profile
Effect of GLP-1 Receptor Agonism on Weight and Caloric Intake in Subjects After Sleeve Gastrectomy
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Mar 2024
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 11 Mar 2024 Planned End Date changed from 30 Dec 2023 to 30 May 2024.
- 27 Nov 2023 Planned End Date changed from 1 Oct 2023 to 30 Dec 2023.
- 06 Aug 2023 Planned End Date changed from 1 Sep 2023 to 1 Oct 2023.